GlassScriptPhysician profile
Brandon C Sloan
NPI 1306253646
$6,230.77
in general payments reported to CMS, 2019-2025
20 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $344 · 2021: $508 · 2022: $2,213 · 2023: $528 · 2024: $898 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,287 · Entertainment: $121 · Gift: $27.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,286.70 |
| Entertainment | $120.96 |
| Gift | $27.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,540.60 | 2019-2025 | Precision 1, Total30, Precision7 |
| Coopervision INC. | $1,072.79 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $556.83 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $539.50 | 2022-2025 | Infuse, Btod, Miebo |
| Johnson & Johnson Vision Care, INC. | $392.41 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $143.64 | 2022 | |
| Rxsight INC | $135.59 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Optos, INC. | $120.96 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $99.17 | 2025 | Opd-III |
| Astellas Pharma US INC | $97.41 | 2024 | Izervay |
| Shire North American Group INC | $96.38 | 2019 | |
| Lkc Technologies, INC. | $92.60 | 2024 | |
| Abb Con-Cise Optical Group LLC | $85.10 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Glaukos Corporation | $73.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $68.49 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.09 | 2022 | |
| Allergan, INC. | $30.09 | 2022 | |
| Biotissue Holdings INC. | $23.75 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $15.68 | 2021 | |
| Optovue, INC. | $10.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.